Lakeway, NY — (US MARKET BUZZ) — 12/19/2014— thenextbigtrade.com, an investment community with a special focus on updating investors with recent news on the U.S. stock...
Celldex Therapeutics, Inc. (NASDAQ:CLDX)’s shares decreased 1.86% to $13.17. The company on June 2 reported data from its ongoing Phase 1 study of the fully human...
StemCells Inc. (NASDAQ:STEM)’s shares declined 1.09% to $1.81. The company on July 15 announced its intent to offer and sell 11,299,435 shares of common stock and...
StemCells Inc. (NASDAQ:STEM)’s shares declined 1.46% to $2.02. The company on July 7 announced the appointment of Alan Trounson, Ph.D. to its Board of Directors. Dr....
StemCells Inc. (NASDAQ:STEM)’s shares declined 1.95% to $2.01. The company on July 7 announced the appointment of Alan Trounson, Ph.D. to its Board of Directors. Dr....
StemCells Inc. (NASDAQ:STEM)’s shares declined 2.42% to $2.02. The company on July 7 announced the appointment of Alan Trounson, Ph.D. to its Board of Directors. Dr....
StemCells Inc (NASDAQ:STEM)’s shares gained 2.39% to $2.14. The company on June 9 announced that based on positive interim results, it has closed enrollment in its...